Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Volatile sympathomimetic with vasoconstrictor effect used as a nasal decongestant. It has hypertensive and tachycardial effects(Marsh 1951). Administration by intranasal spray.
At the date of the last update, there was no published data available on its excretion in human milk.
Product with very few and very old bibliographic references, marketed in few countries.
The virtual absence of pharmacokinetic data does not allow the prediction of its possible excretion in human milk.
Tuaminoheptane has been on the list of prohibited substances by the World Anti-Doping Agency since 2007. (Docherty 2008, Thevis 2007)
Urine levels are detected up to 2 to 4 days after intranasal administration. (Perrenoud 2009, Thevis 2007).
The isolated application, occasional, not continuous and without exceeding the prescribed dose could be compatible with breastfeeding.
Until more published data are known about this drug in relation to breastfeeding, known safer alternatives may be preferable, especially during the neonatal period and in the event of prematurity.